Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.

Although such differences did not reach statistical significance, possibly due to follow-up time and sample size, the data do suggest that non-neoadjuvant chemotherapy and synchronous PC could obtain relatively better survival from the therapy.

also in 111,027 other papers